S100A4 characterize antigen-presenting cancer-associated fibroblasts and predicts surgical outcomes in relapsed ovarian cancer
Therapeutic Advances in Medical Oncology
Published online on April 03, 2026
Abstract
Therapeutic Advances in Medical Oncology, Volume 18, January-December 2026.
Background:Relapsed ovarian cancer (ROC) presents significant therapeutic challenges, and complete resection during secondary cytoreductive surgery (SCR) has been associated with improved survival. However, the contribution of the tumor microenvironment (...
Background:Relapsed ovarian cancer (ROC) presents significant therapeutic challenges, and complete resection during secondary cytoreductive surgery (SCR) has been associated with improved survival. However, the contribution of the tumor microenvironment (...